194 related articles for article (PubMed ID: 28347245)
1. Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.
Bischof J; Westhoff MA; Wagner JE; Halatsch ME; Trentmann S; Knippschild U; Wirtz CR; Burster T
Tumour Biol; 2017 Mar; 39(3):1010428317692227. PubMed ID: 28347245
[TBL] [Abstract][Full Text] [Related]
2. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
Florio T; Barbieri F
Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
4. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma cancer stem cells--from concept to clinical application.
Stopschinski BE; Beier CP; Beier D
Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
[TBL] [Abstract][Full Text] [Related]
6. Localization patterns of cathepsins K and X and their predictive value in glioblastoma.
Breznik B; Limback C; Porcnik A; Blejec A; Krajnc MK; Bosnjak R; Kos J; Van Noorden CJF; Lah TT
Radiol Oncol; 2018 Oct; 52(4):433-442. PubMed ID: 30367810
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.
Mongiardi MP
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):878-83. PubMed ID: 23131159
[TBL] [Abstract][Full Text] [Related]
8. Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches.
Breznik B; Limbaeck Stokin C; Kos J; Khurshed M; Hira VVV; Bošnjak R; Lah TT; Van Noorden CJF
J Mol Histol; 2018 Oct; 49(5):481-497. PubMed ID: 30046941
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
10. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
[TBL] [Abstract][Full Text] [Related]
11. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.
Sheehan JP; Shaffrey ME; Gupta B; Larner J; Rich JN; Park DM
Future Oncol; 2010 Oct; 6(10):1591-601. PubMed ID: 21062158
[TBL] [Abstract][Full Text] [Related]
12. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107
[TBL] [Abstract][Full Text] [Related]
13. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network.
Gürsel DB; Berry N; Boockvar JA
Neurosurgery; 2012 Feb; 70(2):N19-21. PubMed ID: 22251985
[No Abstract] [Full Text] [Related]
14. Methylation by EZH2 activates STAT3 in glioblastoma.
Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
16. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme.
Balenci L; Clarke ID; Dirks PB; Assard N; Ducray F; Jouvet A; Belin MF; Honnorat J; Baudier J
Cancer Res; 2006 Sep; 66(18):9074-82. PubMed ID: 16982749
[TBL] [Abstract][Full Text] [Related]
18. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
19. Overcoming therapeutic resistance in glioblastoma: the way forward.
Osuka S; Van Meir EG
J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
[TBL] [Abstract][Full Text] [Related]
20. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
